A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women (Q83164257)
Jump to navigation
Jump to search
scientific article published on 09 January 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women |
scientific article published on 09 January 2011 |
Statements
A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women (English)
T Cigler
H Richardson
M J Yaffe
C J Fabian
D Johnston
E Nassif
M E Wood
J L Pater
H Hu
S Qi
D Tu
9 January 2011